Barcelona

• A SINGLE-ARM, OPEN-LABEL, PHASE I STUDY TO DETERMINE THE SAFETY, TOLERABILITY, AND PRELIMINARY EFFICACY OF OBE-CEL IN PARTICIPANTS WITH REFR … Recruiting
  2024-519552-93-00 3 2025-11-03 Refractory Progressive Multiple Sclerosis
• A Phase 1 study of JNJ-95437446 in participants with advanced-stage solid tumors Recruiting
  2025-521535-36-00 1 2025-11-03 Locally advanced, metastatic NSCLC, CRC, or HNSCC that has recurred or
• A study to test how different doses of BI 1703880 in combination with ezabenlimab are tolerated in people with different types of advanced c … Recruiting
  2024-511501-37-00 1 2025-10-31 Advanced solid tumours
• Study of encorafenib plus cetuximab as rechallenge treatment of BRAF V600E-mutant metastatic colorectal cancer patients: the RefIsh trial Recruiting
  2023-509564-22-00 4 2025-10-30 Patients with BRAF V600E-mutant metastatic colorectal cancer (mCRC) wh
• A Phase 1b/2, Study of I-DXd in Combination with Atezolizumab with or without Carboplatin in First-line ES‑SCLC Recruiting
  2023-509629-36-00 9 2025-10-29 Extensive-stage Small Cell Lung Cancer (ES-SCLC)
• TRITON-CM: A Study to Evaluate Nucresiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy Recruiting
  2024-519917-72-00 5 2025-10-29 Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with C
• A Phase 3 Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer’s Disease Recruiting
  2025-520747-32-00 5 2025-10-29 Mild to moderate Alzheimer’s Disease
• Clinical trial to assess the efficacy and safety of a post-coital intravaginal gel of PKB171 in couples with mild male factor infertility. Recruiting
  2023-503850-11-00 10 2025-10-28 Oligospermia and/or asthenozoospermia
• A Phase 3 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Deucravacitinib (BMS-986165) in Adolescent Participants with Moder … Recruiting
  2023-506296-97-00 5 2025-10-28 Moderate to Severe Plaque Psoriasis
• A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin i … Recruiting
  2024-518365-10-00 5 2025-10-28 Previously Untreated Advanced or Metastatic Non-Squamous Non−Small Cel
• OMTX705-006 Phase 1b Recruiting
  2025-521872-69-00 3 2025-10-28 Advanced/Metastatic Pancreatic Adenocarcinoma
• A trial to determine the dose, and evaluate the safety and pharmacokinetics of lutetium Lu 177 edotreotide in children with somatostatin rec … Recruiting
  2024-512831-66-00 3 2025-10-24 Pediatric participants aged two to less than 18 years old with somatos
• An Open-label, Phase 4 Study of Nirogacestat in Adult Premenopausal Females with Desmoid Tumor/Aggressive Fibromatosis (DT/AF). Recruiting
  2024-515215-21-00 6 2025-10-24 DESMOID TUMOURS/AGGRESSIVE FIBROMATOSIS (DT/AF)
• A Phase 2 Study of the Effects and Safety of PF-07328948 in Adults with Heart Failure (BRANCH-HF) Recruiting
  2024-518438-94-00 4 2025-10-24 Heart failure
• A Study of LY4175408 in Participants With Advanced or Metastatic Solid Tumors. Recruiting
  2025-521916-20-00 1 2025-10-24 Cancer
• A Phase 1 Study of NDI-219216 in Patients with Advanced Solid Tumors with and without Microsatellite Instability and/or Deficient Mismatch R … Recruiting
  2025-522774-36-00 1 2025-10-24 Advanced solid tumors
• Study to assess the maintenance of effect of NBI-1065845 as an adjunctive treatment in participants with Major Depressive Disorder (MDD) Recruiting
  2025-520541-72-00 5 2025-10-22 Major Depressive Disorder
• Neoadjuvant Cemiplimab Plus Imiquimod in Cutaneous Basal Cell Carcinoma. Recruiting
  2025-520698-38-00 9 2025-10-22 Cutaneous Basal Cell Carcinoma
• C4951063: A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine Recruiting
  2024-517121-10-00 5 2025-10-17 Menstrual Migraine
• Inhaled sedation in the critically ill patient Recruiting
  2024-518521-14-00 6 2025-10-17 Critical condition
• A study to evaluate dosing schedules of mirvetuximab soravtansine in patients with epithelial ovarian, primary peritoneal, or fallopian tube … Recruiting
  2024-517184-23-00 4 2025-10-16 platinum-resistant advanced high-grade epithelial ovarian, primary per
• A study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in participants with moderate to severe hid … Recruiting
  2025-520564-17-00 5 2025-10-16 Hidradenitis suppurativa (HS)
• Open Label Extension Clinical Trial of Vormatrigine in Adult Patients with Epilepsy. Recruiting
  2025-521640-38-00 5 2025-10-16 Focal onset seizures or primary generalized tonic-clonic seizures.
• Study of IADADEMSTAT for the Treatment of Sickle Cell Disease. Recruiting
  2025-521838-29-00 3 2025-10-16 Sickle Cell Disease

Showing 865–888 of 3,391 trials